cannabis

Making the Case for Regulated Marijuana
Making the Case for Regulated MarijuanaPharmacists urged to support controls to the marijuana market but oppose criminalization.
Cannabis-derived epilepsy drug on the horizonA pharmaceutical formulation of purified cannabidiol, a cannabinoid without euphoric side effects, is expected to launch in the second half of this year.
Cannabis for skin care?It’s been called the next “it” beauty ingredient, but one expert says the hype is ahead of the research.
No Matter the Law, Pharmacists Need to Know About Cannabis
No Matter the Law, Pharmacists Need to Know About CannabisPharmacists should take a leadership position on medical cannabis.
Can cannabis succeed where other compounds have failedUse of a novel semi-fluorinated alkane drug delivery technology as a vehicle to deliver cannabinoids to the ocular surface reached target tissues without systemic side effects in preclinical studies.
ASHP Celebrates 75th Anniversary at Midyear 2017This year, pharmacists can look forward to a variety of great topics and meetings in Orlando.
DIR Fees, Medical Marijuana Among Hot Topics at NCPA ConventionWhat you need to know about the upcoming NCPA convention.
Why a Pharmacy School Cancelled Marijuana Classes
Why a Pharmacy School Cancelled Marijuana ClassesMedical cannabis classes will no longer be held at the University of Maryland-Baltimore.
The Top 7 Craziest Drugs in the Pipeline
The Top 7 Craziest Drugs in the PipelineNot all drugs are incredible—and sometimes even the incredible ones have weird origins.
Cannabis for Credits
Cannabis for CreditsClinical rotation gives students unique view of medical cannabis industry.